Shampoo to support your styler.
Preview text: 10% off with System Builder™
No image available for this email.
- Subject
- Shampoo to support your styler.
- Preview text
- 10% off with System Builder™
- From
- contact@
saltgrooming.com - Brand
- Salt Grooming
- ESP
- Klaviyo
- Sent
- Tue Jul 28, 2026, 6:00 AM ET
- Size
- 53 KB
- Images
- 13
- Links
- 15, 1 of them buttons
- Subject length
- 31 characters
Against Salt Grooming's usual
Sent in the 6 AM hour, which holds 16% of its emails; 19% arrive in the 5 AM hour. The subject is 31 characters; its average is 28.
Email headers
What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.
- From
- SALT <[email protected]>
- Subject
- Shampoo to support your styler.
- Date
- Tue, 28 Jul 2026 10:00:50 +0000 (UTC)
- Message-ID domain
- geopod-ismtpd-13
- Return-Path domain
- contact.saltgrooming.com
- DKIM signature
- d=saltgrooming.com s=kl2
- List-Unsubscribe
- Present, one-click
Servers it passed through, newest first
- from o1375.shared.klaviyomail.com [149.72.197.103] by our receiving server with ESMTPS
- by recvd-canary-…-q8hd6 with SMTP
- from (unnamed) by geopod-ismtpd-13 with HTTP
Other sending headers (names only): X-Kmail-Account, X-Kmail-Message, X-Kmail-Ops, X-Report-Abuse, X-SG-EID, X-SG-ID, X-Entity-ID
Sent just before and after
| Aug 5, 2026 2:01 PM | Time to address hair loss? | |
| Aug 3, 2026 6:00 AM | Want to see SALT at your barber's? | |
| Jul 30, 2026 7:30 AM | Bad hair days aren’t “bad luck” | |
| Jul 28, 2026 6:00 AM | Shampoo to support your styler. (this email) | |
| Jul 26, 2026 5:30 AM | Frequent flyer? You need this. | |
| Jul 24, 2026 5:00 AM | 1 month into SALT 2.0 | |
| Jul 23, 2026 12:02 PM | Don’t forget your 10% off. |
More from Salt Grooming
All Salt Grooming emailsNov 5, 2026 2:01 PM
Will you still be using it in February?
Nov 2, 2026 6:00 AM
Oct 31, 2026 6:15 AM
Oct 29, 2026 3:30 PM
Oct 28, 2026 5:30 AM
Oct 25, 2026 3:30 PM
Buying the wrong products is expensive
Oct 22, 2026 2:01 PM
A clinically proven breakthrough
Oct 16, 2026 6:00 AM







